Ben Naccarato
Analyst · Heartland Funds
Thank you, Mark. I'll start with revenue. Our total revenue from continuing operations for the second quarter was $13.2 million compared to $12.7 million in the second quarter last year or an increase of 3.5%. Our Service segment revenue increased $929,000 or 30%, which was partially offset by a reduction in our Treatment segment of $484,000 or 5%. This decrease at Treatment was primary due to the closure of our M&EC facility, which last year recognized $1.7 million of revenue and only $76,000 in this quarter as we continued work towards transitioning the capabilities from that facility over to our other plants. For the six months ended June 30, '18, our total revenue was $25.8 million, consistent with the $25.4 million in the prior year. And again, as with the quarter, the year-to-date Service revenue exceeded the prior year, while the year-to-date Treatment segment was lower than the prior year, primarily due to the reduction at the M&EC facility. On the cost of sales side, our cost of sales were $11.1 million, up from the prior year cost of $10.4 million. Within the quarter, we did book $1.2 million of additional reserves related to the M&EC closure. Without this expense, our cost of sales would have shown a small decrease of approximately $459,000, even though we had more revenue in the quarter. Our gross profit for the quarter decreased by $2.4 million in Q2 of '17 -- I'm sorry, a decrease from $2.4 million in Q2 of last year to $2 million this year, a decrease of $311,000 or 13%. Again, the impact of the $1.2 million reserve for M&EC closure negatively impacted the gross profit. Excluding this increase in the reserve, our gross profit would have increased by approximately $904,000. On the year-to-date, gross profit was $5.4 million compared to $5.1 million last year. And finally, again, this gross profit includes this additional reserve at M&EC, and excluding it, our gross profit improved by approximately $1.5 million on comparable revenue. Our SG&A costs for the quarter were $2.6 million, down from $2.8 million last year, primarily due to lower costs for outside services and bad debt. For six months ended June 30, our SG&A expenses dropped about $264,000 due to lower payroll-related costs. In the second quarter, of note, we booked a net gain of $1.6 million related to the share exchange and cancellation of our preferred shares of our M&EC subsidiary. This transaction removed approximately $1.3 million of M&EC preferred shares from our balance sheet as well as approximately $1 million of accrued dividends. We had income from continuing operations net of taxes for the quarter of $788,000 compared to a loss of $1.2 million last year, an improvement of $2 million. For the six months ended June 30, our income from continuing operations net of taxes was $1 million compared to a loss of $1.9 million in the prior year. We had net income attributable to common shareholders of $610,000 compared to last year's net loss of $1.2 million. And over six months, our net income attributable to common shareholders improved from a loss of $1.9 million in prior year to a profit of $745,000 this year. We had net income per share for the quarter of $0.05 compared to a loss per share of $0.10 in the prior year. Our adjusted EBITDA from continuing operations, as we defined in this morning's press release, was $846,000 compared to $586,000 last year. Our adjusted EBITDA from continuing operations year-to-date is now $1.6 million compared to $1.4 million last year. Turning to the balance sheet. As compared to December 31, 2017, our cash balance at the end of the year was $2.2 million, up from $1.1 million at year-end, reflecting the improved collections of our receivables. Collectively, our accounts receivables [indiscernible] current unbilled receivables dropped $3.4 million, reflecting our improved collection and billing efforts. Our current liabilities were down approximately $1.7 million, reflecting the company's improved liquidity position despite the increase in the closure cost of the $1.2 million. Our backlog at the end of the second quarter was $7.4 million compared to $7.7 million at year-end and $6.5 million in June of 2017. Our current closure reserve at the M&EC facility was $924,000 at the end of the quarter. Our total debt at the end of the quarter was $3.5 million, and that's net of all debt issuance costs, all of which is primarily owed to our credit facility, PNC Bank. Finally, I'll summarize our year-to-date cash flow activity in the second quarter. Our cash provided for continuing operations was $2.7 million. Our cash used by discontinued operations was $322,000. Our cash used for investing in continuing operations was $528,000, of which $554,000 was for cap spending. Cash provided from discontinued ops is $36,000, and cash used for financing was $579,000, which represented primarily from our monthly payments on our term loan of $610,000 and offset by cash receives for the issuance of common stock on exercise of options. With that, operator, I'll now open the call for questions.